regulatory pathway and applications in drug development for rare diseases
Published 9 months ago • 103 plays • Length 1:24:07Download video MP4
Download video MP3
Similar videos
-
2:27
jane larkindale - why are c-path drug development tools important in rare disease drug development?
-
29:30
accelerating drug development for rare diseases through data sharing and analysis
-
11:08
rare disease endpoint advancement rdea pilot program
-
4:33
the drug development process
-
3:48
how has the presence or lack of data changed drug development for platelet disorders?
-
48:02
rdca-dap - value of integrated data and analytics in rare disease drug development
-
4:12
why are high-quality standardized databases so critical for drug development?
-
57:08
industry perspective on drug development in rare diseases
-
46:37
clinical trial simulation tools advancing treatments in rare disease
-
8:03
rdca-dap: how the data and analytics platform accelerates rare disease drug development
-
3:44
rare disease challenges in each step of the drug development process
-
22:01
optimization of clinical trial design for rare disease through modeling: example in duchenne’s
-
36:48
c-path's rare & orphan disease conference - ontology applications in rare disease
-
1:50
rare disease drug development education series trailer
-
29:30
accelerating drug development for rare diseases through data sharing and analysis
-
4:17
rdca-dap: shortening the timeline for developing new treatments for rare diseases
-
30:31
drug development and regulation in the age of precision medicine
-
53:31
ai-powered real-world simulations for faster and value-based rare disease drug development
-
57:50
drug development for rare diseases: a community conversation